| 1 |
Kang T, Cha GD, Park OK, Cho HR, Kim M, Lee J, Kim D, Lee B, Chu J, Koo S, Hyeon T, Kim DH, Choi SH. Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment. ACS Nano 2023. [PMID: 36926815 DOI: 10.1021/acsnano.2c10094] [Reference Citation Analysis]
|
| 2 |
Chen X, Gong Y, Chen W. Advanced Temporally-Spatially Precise Technologies for On-Demand Neurological Disorder Intervention. Adv Sci (Weinh) 2023;:e2207436. [PMID: 36929323 DOI: 10.1002/advs.202207436] [Reference Citation Analysis]
|
| 3 |
Hu L, Song C, Li H, Gao Y, Zhang J, Gao T, Wei Y, Xu Z, Xue W, Huang S, Wen H, Li Z, Wu J. Oxidized Dextran/Chitosan Hydrogel Engineered with Tetrasulfide-Bridged Silica Nanoparticles for Postsurgical Treatment. Macromol Biosci 2023;:e2200565. [PMID: 36871156 DOI: 10.1002/mabi.202200565] [Reference Citation Analysis]
|
| 4 |
Cheng R, Santos HA. Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy. Adv Healthc Mater 2023;12:e2202063. [PMID: 36479842 DOI: 10.1002/adhm.202202063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Chen H, Li T, Liu Z, Tang S, Tong J, Tao Y, Zhao Z, Li N, Mao C, Shen J, Wan M. A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma. Nat Commun 2023;14:941. [PMID: 36804924 DOI: 10.1038/s41467-022-35709-0] [Reference Citation Analysis]
|
| 6 |
Martins C, Pacheco C, Moreira-Barbosa C, Marques-Magalhães Â, Dias S, Araújo M, Oliveira MJ, Sarmento B. Glioblastoma immuno-endothelial multicellular microtissue as a 3D in vitro evaluation tool of anti-cancer nano-therapeutics. J Control Release 2023;353:77-95. [PMID: 36410614 DOI: 10.1016/j.jconrel.2022.11.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Martins AM, Brito A, Barbato MG, Felici A, Reis RL, Pires RA, Pashkuleva I, Decuzzi P. Efficacy of molecular and nano-therapies on brain tumor models in microfluidic devices. Biomater Adv 2022;144:213227. [PMID: 36470174 DOI: 10.1016/j.bioadv.2022.213227] [Reference Citation Analysis]
|
| 8 |
Sumohan Pillai A, Alexander A, Sri Varalakshmi G, Manikantan V, Allben Akash B, Enoch IV. Cyclodextrin and folate functionalized polymer nanocarriers: Chain length dependent properties. European Polymer Journal 2022;179:111550. [DOI: 10.1016/j.eurpolymj.2022.111550] [Reference Citation Analysis]
|
| 9 |
Cha GD, Jung S, Choi SH, Kim DH. Local Drug Delivery Strategies for Glioblastoma Treatment. Brain Tumor Res Treat 2022;10:151-7. [PMID: 35929112 DOI: 10.14791/btrt.2022.0017] [Reference Citation Analysis]
|
| 10 |
Dang W, Chen W, Ju E, Xu Y, Li K, Wang H, Wang K, Lv S, Shao D, Tao Y, Li M. 3D printed hydrogel scaffolds combining glutathione depletion-induced ferroptosis and photothermia-augmented chemodynamic therapy for efficiently inhibiting postoperative tumor recurrence. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01454-1] [Reference Citation Analysis]
|
| 11 |
Hauck M, Dittmann J, Zeller-plumhoff B, Madurawala R, Hellmold D, Kubelt C, Synowitz M, Held-feindt J, Adelung R, Wulfinghoff S, Schütt F. Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release. Pharmaceutics 2022;14:777. [DOI: 10.3390/pharmaceutics14040777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Felici A, Schlich M, Di Mascolo D, Goldoni L, Lisa Palange A, Decuzzi P. Boosting the Therapeutic Efficacy of Discoidal Nanoconstructs against Glioblastoma with Rationally Designed PEG-Docetaxel Conjugates. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Menna G, Manini I, Cesselli D, Skrap M, Olivi A, Ius T, Della Pepa GM. Immunoregulatory effects of glioma-associated stem cells on the glioblastoma peritumoral microenvironment: a differential PD-L1 expression from core to periphery? Neurosurg Focus 2022;52:E4. [PMID: 35104793 DOI: 10.3171/2021.11.FOCUS21589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 14 |
Yang T, Hu Y, Miao J, Chen J, Liu J, Cheng Y, Gao X. A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization. Acta Pharmaceutica Sinica B 2022;12:2658-71. [DOI: 10.1016/j.apsb.2022.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Schoen S Jr, Kilinc MS, Lee H, Guo Y, Degertekin FL, Woodworth GF, Arvanitis C. Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound. Adv Drug Deliv Rev 2022;180:114043. [PMID: 34801617 DOI: 10.1016/j.addr.2021.114043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 16 |
Luo G, Feng R, Li W, Chen Y, Sun Y, Ma J, Duo Y, Wen T. Dcf1 induces glioblastoma cells apoptosis by blocking autophagy. Cancer Med 2021. [PMID: 34799992 DOI: 10.1002/cam4.4440] [Reference Citation Analysis]
|
| 17 |
Serio F, Silvestri N, Kumar Avugadda S, Nucci GEP, Nitti S, Onesto V, Catalano F, D'Amone E, Gigli G, Del Mercato LL, Pellegrino T. Co-loading of doxorubicin and iron oxide nanocubes in polycaprolactone fibers for combining Magneto-Thermal and chemotherapeutic effects on cancer cells. J Colloid Interface Sci 2021;607:34-44. [PMID: 34492351 DOI: 10.1016/j.jcis.2021.08.153] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Bastiancich C, Bozzato E, Henley I, Newland B. Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review. J Control Release 2021;337:296-305. [PMID: 34298055 DOI: 10.1016/j.jconrel.2021.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
